Assessing suicide risk using implicit and explicit methods
Implicit and Explicit Assessment of Suicide Risk
This study is testing a computer tool to see how hidden thoughts about suicide change over time in people who have or haven't thought about suicide openly or tried to harm themselves.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 108 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Amiens, Picardie) |
| Trial ID | NCT05903469 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the evolution of implicit suicidal ideation over time using the Implicit Association Test (IAT), a computer-based tool developed to predict suicidal recurrence. Participants will be recruited from the emergency unit of CHU Amiens and will undergo assessments at the time of inclusion, as well as at 6 and 12 months. The study will differentiate between individuals with and without explicit suicidal ideation and those with and without previous suicide attempts. The goal is to gather data on how implicit attitudes towards suicide change over time.
Who should consider this trial
Good fit: Ideal candidates include adults presenting to emergency services for psychiatric reasons who can provide informed consent and speak French fluently.
Not a fit: Patients with neurological disorders, acute psychotic episodes, or those under the influence of substances impairing cognitive function may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the prediction and prevention of suicide by providing a better understanding of implicit suicidal ideation.
How similar studies have performed: Previous studies have shown promise in using implicit measures for predicting suicide risk, but this specific approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Person presenting to emergencies for psychiatric reasons * Adult person * Free and informed consent signed * Person speaking and writing French fluently Exclusion Criteria: * Neurological disorders or major cognitive deterioration: presence of confusion * Acute psychotic decompensation * Troubled acute behavior * Abuse Impregnation of a toxic substance and / or drug impairing cognitive functions at the time of assessment * Adult under protective measure.
Where this trial is running
Amiens, Picardie
- Centre Hospitalier Universitaire d'Amiens — Amiens, Picardie, France (Recruiting)
Study contacts
- Study coordinator: Jérôme Thilliez, MD
- Email: thilliez.jerome@chu-amiens.fr
- Phone: 03.22.66.82.90
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.